Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis
1.0 Credit / Dermatology, Immunology
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Preven...
2.0 Credits / Ophthalmology/Optometry
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Preven...
2.0 Credits / Ophthalmology/Optometry
View More
Maximizing Patient Safety and Efficacy With Oxymetazoline OTC Products and the Management of Nasal Congestion:...
2.0 Credits / OTC
View More
Maximizing Patient Safety and Efficacy With Oxymetazoline OTC Products and the Management of Nasal Congestion:...
2.0 Credits / OTC
View More
Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics
1.0 Credit / Dermatology, Immunology
View More
Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis
1.5 Credits / Gastroenterology
View More
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
1.0 Credit / Neurology
View More
Emergency Prescription Assistance Program Deployed in North Carolina Following Hurricane Helene
October 7th 2024Eligible patients can receive a 30-day supply of covered drugs and medical supplies that can be renewed every 30 days for as long as an Emergency Prescription Assistance Program (EPAP) is active.
Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters
October 4th 2024Trisha Winroth, PharmD, and Ashly McPhillips, PharmD, discuss how the shingles vaccine works to prevent reactivation of the varicella-zoster virus and reduce shingles risk, and how to effectively address patient concerns and misconceptions about the vaccine’s benefits, symptoms, and complications of shingles.
Study Finds Upsurge of Shingles Vaccination in Medicare Part D Following Elimination of Cost Sharing
October 3rd 2024The Inflation Reduction Act's zero cost-sharing policy resulted in significant increases in shingles vaccines dispensed to individuals under Part D, compared with those who are commercially insured.